THC Farmaceuticals Inc
THC Farmaceuticals, Inc. owns and operates non-financial institution cash-dispensing automated teller machines at third-party owned retail and commercial locations. The company's machines are placed in hotels, stores, bowling alleys, and other high customer traffic areas for small and medium sized businesses. As of June 30, 2015, it had a total of eight machines for public use along the Wasatch F… Read more
Market Cap & Net Worth: THC Farmaceuticals Inc (CBDG)
THC Farmaceuticals Inc (PINK:CBDG) has a market capitalization of $244.78K ($244.78K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #49909 globally and #15245 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying THC Farmaceuticals Inc's stock price $0.01 by its total outstanding shares 18131600 (18.13 Million).
THC Farmaceuticals Inc Market Cap History: 2015 to 2025
THC Farmaceuticals Inc's market capitalization history from 2015 to 2025. Data shows change from $12.69 Million to $244.78K (-34.34% CAGR).
THC Farmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how THC Farmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
222.11x
THC Farmaceuticals Inc's market cap is 222.11 times its annual revenue
1742.66x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
5.20x
THC Farmaceuticals Inc's market cap is 5.20 times its annual earnings
0.11x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $6.71 Million | $17.07K | -$136.12K | 392.94x | N/A |
| 2017 | $9.38 Million | $12.95K | -$7.30K | 724.06x | N/A |
| 2018 | $12.87 Million | $12.21K | -$15.24K | 1054.51x | N/A |
| 2019 | $5.26 Million | $10.19K | -$498.57K | 515.86x | N/A |
| 2020 | $2.72 Million | $7.58K | -$60.45K | 358.80x | N/A |
| 2021 | $1.11 Million | $2.23K | -$8.42K | 495.09x | N/A |
| 2022 | $2.22 Million | $10.00K | $426.90K | 222.11x | 5.20x |
Competitor Companies of CBDG by Market Capitalization
Companies near THC Farmaceuticals Inc in the global market cap rankings as of March 18, 2026.
Key companies related to THC Farmaceuticals Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #158 globally with a market cap of $118.01 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.58 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #158 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $118.01 Billion | $466.10 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.58 Billion | $756.91 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
THC Farmaceuticals Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, THC Farmaceuticals Inc's market cap moved from $12.69 Million to $ 244.78K, with a yearly change of -34.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $244.78K | +141.07% |
| 2024 | $101.54K | -74.55% |
| 2023 | $398.90K | -82.04% |
| 2022 | $2.22 Million | +100.82% |
| 2021 | $1.11 Million | -59.31% |
| 2020 | $2.72 Million | -48.31% |
| 2019 | $5.26 Million | -59.15% |
| 2018 | $12.87 Million | +37.30% |
| 2017 | $9.38 Million | +39.76% |
| 2016 | $6.71 Million | -47.14% |
| 2015 | $12.69 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of THC Farmaceuticals Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $244.78K USD |
| MoneyControl | $244.78K USD |
| MarketWatch | $244.78K USD |
| marketcap.company | $244.78K USD |
| Reuters | $244.78K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.